NCT00694993 - Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 17, 2007

Primary Completion Date

May 26, 2008

Study Completion Date

May 26, 2008

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG

GSK1004723

GSK1004723 will be supplied as intranasal sprays aqueous suspensions for intranasal spray administration.

DRUG

Placebo

Placebo will be supplied as intranasal sprays aqueous suspensions for intranasal spray administration.

Trial Locations (1)

GSK Investigational Site, Berlin